Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-22

Clinical Trial Update: Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome

View source ↗

Summary

A clinical trial is recruiting to examine how genetic factors influence the severity of DiGeorge syndrome/22q11.2 Deletion Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: DiGeorge Syndrome, 22q11.2 Deletion Syndrome | Status: RECRUITING